Edgewise Therapeutics (EWTX) Earnings Date & Reports
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EWTX is expected to report earnings to rise 1.26% to -42 cents per share on May 08
Q1'25
Est.
$-0.43
Q4'24
Est.
$-0.42
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.34
Q1'24
Beat
by $0.06
The last earnings report on March 03 showed earnings per share of -41 cents, meeting the estimate of -41 cents. With 7.72M shares outstanding, the current market capitalization sits at 1.43B.